Literature DB >> 6172930

Clinical variations in bullous pemphigoid with respect to early symptoms.

E Asbrink, A Hovmark.   

Abstract

We report the clinical variations and the duration of prodromal symptoms in 20 patients with bullous pemphigoid. Nearly two-thirds of the patients had prodromal symptoms. THe duration of the prodromal eruptions was up to 6 weeks if papular and/or urticarial and up to 2 years if eczematous, before the blisters appeared. Evidently longer prodromal periods were found in the present study than in earlier investigations. It is not known when in the course of the disease the direct immunofluorescence will be positive. Two of our patients were immunofluorescence-positive 1 and 2 weeks respectively before the blisters appeared. A common clinical manifestation in this study was vesicles on palms and/or soles. These eruptions, particularly as an early symptom, may cause misinterpretation in patients with bullous pemphigoid.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6172930

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  6 in total

1.  Photoletter to the editor: An eczema-like, pruritic, nonbullous form of bullous pemphigoid.

Authors:  Kui Young Park; Moo Yeol Hyun; In Kwon Yeo; Seong Jun Seo; Chang Kwun Hong
Journal:  J Dermatol Case Rep       Date:  2015-06-30

Review 2.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 4.  Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature.

Authors:  Yosuke Mai; Wataru Nishie; Kazumasa Sato; Moeko Hotta; Kentaro Izumi; Kei Ito; Kazuyoshi Hosokawa; Hiroshi Shimizu
Journal:  Front Immunol       Date:  2018-04-12       Impact factor: 7.561

Review 5.  Dyshidrosiform Bullous Pemphigoid.

Authors:  Philip R Cohen
Journal:  Medicina (Kaunas)       Date:  2021-04-20       Impact factor: 2.430

6.  Dyshidrosiform Bullous Pemphigoid: Case Reports and Review.

Authors:  Philip R Cohen
Journal:  Cureus       Date:  2020-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.